EPRX

Eupraxia Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website -
Employees(FY) -
ISIN CA29842P1053

Performance

+0.34%

1W

+12.21%

1M

-45.25%

3M

-25.72%

6M

-29.35%

YTD

-43.76%

1Y

Profile

-

Advanced Technical Analysis

Technical Analysis of EPRX 2024-05-10

Overview:

In analyzing the technical indicators for EPRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...

Recent News & Updates

2024-05-13 19:00
Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024(Prnewswire)
2024-05-08 05:03
Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update(Prnewswire)
2024-05-01 19:00
Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board(Prnewswire)
2024-04-10 19:00
Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024(Prnewswire)
2024-04-07 19:00
Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference(Prnewswire)
2024-04-04 19:00
Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today(Prnewswire)

Page 1 of 1

previousnext

Home

Market Lens

Ideas Explorer

History

Recent Activity